论文信息 - CEP-28122, a Highly Potent and Selective Orally Active Inhibitor of Anaplastic Lymphoma Kinase with Antitumor Activity in Experimental Models of Human Cancers - 字舞流文

CEP-28122, a Highly Potent and Selective Orally Active Inhibitor of Anaplastic Lymphoma Kinase with Antitumor Activity in Experimental Models of Human Cancers

G. Inghirami | B. Ruggeri | D. Gingrich | F. Cristofani | B. Dorsey | T. Angeles | M. Ator | Mark S. Albom | L. Aimone | G. R. Ott | R. Machiorlatti | C. Abele | W. Wan | Lihui Lu | M. Quail | M. Cheng